In the Spotlight
Ayako Inagaki, director of human and social development at ADB’s Southeast Asia Regional Department, helps oversee ADB’s COVID-19 portfolio for Southeast Asia—$5.8 billion and counting.
ADB has joined with leading public health experts, vaccine regulators, and policy makers to form an advisory group to provide its developing member countries with expert technical and scientific advice on the quality, safety, and effectiveness of COVID-19 pandemic vaccines.
The Asian Development Bank has approved a loan of $150 million for Sri Lanka to purchase vaccines against the coronavirus disease (COVID-19) and improve vaccination information, delivery, and monitoring systems.
ADB has launched a $9 billion vaccine initiative—the Asia Pacific Vaccine Access Facility (APVAX)—offering rapid and equitable support to its developing member countries as they procure and deliver effective and safe COVID-19 vaccines.